KRRO logo

KRROKorro Bio Inc

$11.12
$0.39
(3.66%)
Today
Closed $11.05
$0.07
(0.63%)
After Hours
Updated: 05:10 PM EDT
EarningsAug 11
Mkt Cap$153.74M
Vol143,444.00
News
all
press releases
Korro Bio (KRRO) to Release Quarterly Earnings on Wednesday
Korro Bio (NASDAQ:KRRO) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at...
MarketBeat
News Placeholder
More News
News Placeholder
What Makes Korro Bio, Inc. (KRRO) a New Buy Stock
Korro Bio, Inc. (KRRO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks
News Placeholder
Korro Bio, Inc. (NASDAQ:KRRO) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Korro Bio, Inc. (NASDAQ:KRRO - Get Free Report) have earned an average rating of "Moderate Buy" from the eleven analysts that are currently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, four have given a hold rating, five hav...
MarketBeat
News Placeholder
Korro Bio (NASDAQ:KRRO) Stock Price Down 0.8% - Should You Sell?
Korro Bio (NASDAQ:KRRO) Stock Price Down 0.8% - Here's Why...
MarketBeat
News Placeholder
JPMorgan Chase & Co. Buys 196,079 Shares of Korro Bio, Inc. $KRRO
JPMorgan Chase & Co. grew its stake in Korro Bio, Inc. (NASDAQ:KRRO - Free Report) by 6,185.5% during the third quarter, according to the company in its most recent filing with the Securities and...
MarketBeat
News Placeholder
Korro Bio, Inc. (NASDAQ:KRRO) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Korro Bio, Inc. (NASDAQ:KRRO - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eleven research firms that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, four have assigned a hold rati...
MarketBeat
News Placeholder
Korro Bio Stock Gains After Tough 2025 - New Drug Candidate, Analyst Upgrades Boost Outlook
Korro Bio stock rises after earnings as analysts upgrade outlook, highlight new drug candidate, and long-term growth plans.read more...
Benzinga
News Placeholder
Korro Bio (NASDAQ:KRRO) Rating Increased to Outperform at Raymond James Financial
Raymond James Financial upgraded Korro Bio from a "market perform" rating to an "outperform" rating and set a $23.00 price target for the company in a research report on Friday...
MarketBeat
News Placeholder
Insider Buying: Korro Bio (NASDAQ:KRRO) Major Shareholder Buys 207,100 Shares of Stock
Korro Bio, Inc. (NASDAQ:KRRO - Get Free Report) major shareholder Scott Sandell acquired 207,100 shares of Korro Bio stock in a transaction that occurred on Tuesday, March 10th. The shares were...
MarketBeat
News Placeholder
Korro Bio (NASDAQ:KRRO) Major Shareholder Buys $2,300,881.00 in Stock
Korro Bio, Inc. (NASDAQ:KRRO - Get Free Report) major shareholder Rick Yang purchased 207,100 shares of the company's stock in a transaction on Tuesday, March 10th. The stock was bought at an average...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.